| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $989.9M | $935.3M | $874.6M |
| YoY Revenue Growth % | +5.8% | +6.9% | — |
| Gross Profit | $583.1M | $539.0M | — |
| Gross Margin % | 58.9% | 57.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $75.1M | $68.7M | $68.4M |
| Operating Margin % | 7.6% | 7.3% | 7.8% |
| Net Income (GAAP) | $45.5M | $35.9M | $110.3M |
| EBITDA (Normalized) | $109.3M | $106.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $166.7M | $32.6M | $140.6M |
| Capital Expenditures (CapEx) | $42.9M | $47.2M | — |
| Free Cash Flow (FCF) | $123.8M | -$14.6M | $140.6M |
| FCF Margin % | 12.5% | -1.6% | 16.1% |
| Return on Invested Capital (ROIC %) | 11.4% | 10.3% | — |
| Cash & Short-Term Equivalents | $178.2M | $111.3M | — |
| Total Debt (Short + Long Term) | $116.6M | $119.6M | — |
| Total Stockholders' Equity | $581.0M | $518.4M | — |